Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Debt-to-Equity : 0.00 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Beijing Chunlizhengda Medical Instruments Co Debt-to-Equity?

Beijing Chunlizhengda Medical Instruments Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$1.3 Mil. Beijing Chunlizhengda Medical Instruments Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$0.6 Mil. Beijing Chunlizhengda Medical Instruments Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$3,147.3 Mil. Beijing Chunlizhengda Medical Instruments Co's debt to equity for the quarter that ended in Dec. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity or its related term are showing as below:

HKSE:01858's Debt-to-Equity is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 0.22
* Ranked among companies with meaningful Debt-to-Equity only.

Beijing Chunlizhengda Medical Instruments Co Debt-to-Equity Historical Data

The historical data trend for Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Chunlizhengda Medical Instruments Co Debt-to-Equity Chart

Beijing Chunlizhengda Medical Instruments Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

Beijing Chunlizhengda Medical Instruments Co Quarterly Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	N/A

Competitive Comparison of Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity

For the Medical Devices subindustry, Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity falls into.

Beijing Chunlizhengda Medical Instruments Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Beijing Chunlizhengda Medical Instruments Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.336	+	0.582)	/	3147.313
	=	0.00

Beijing Chunlizhengda Medical Instruments Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.336	+	0.582)	/	3147.313
	=	0.00

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Beijing Chunlizhengda Medical Instruments Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Beijing Chunlizhengda Medical Instruments Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Chunlizhengda Medical Instruments Co Ltd (HKSE:01858) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

688236:China

Address

No. 10 Xinmi Xi Er Road, Southern District of Tongzhou, Economic Development Zone, Tongzhou District, Beijing, CHN

Website

http://www.clzd.com

Beijing Chunlizhengda Medical Instruments Co Ltd is an orthopedic medical device company. It is engaged in the research, development, manufacture, and sale of orthopedic medical devices, including joint prosthesis products and spinal products. The products offered by the company are classified into three categories, namely Standard joint prosthesis products, Custom joint prosthesis products, and Spinal products. It operates in the business segment of manufacture and trading of surgical implants, instruments and related products.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Citigroup Inc.	2502 Approved lending agent
Fidelity China Special Situations Plc	2101 Beneficial owner
Taiping Assets Management (hk) Company Limited	2102 Investment manager
Taiping Trustees Limited	2301 Trustee

Beijing Chunlizhengda Medical Instruments Co (HKSE:01858) Headlines

No Headlines